Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M664Revenue (TTM) $M358Net Margin (%)-7.7Altman Z-Score2.8
Enterprise Value $M742EPS (TTM) $-0.8Operating Margin %5.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)4.3Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %2.6Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow13.8y-y EBITDA Growth Rate %226ROA % (ttm)-3.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-5.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M37.2ROIC % (ttm)-6.9Gross Margin Increase y-yN

Gurus Latest Trades with ANGO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ANGO is held by these investors:



ANGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Burgstahler David FDirector, 10% Owner 2016-11-18Sell2,091,294$15.6814.03view
Avista Capital Partners GP, LL10% Owner 2016-11-18Sell2,091,294$15.6814.03view
Burgstahler David FDirector, 10% Owner 2016-08-05Sell2,250,000$14.6222.3view
Avista Capital Partners GP, LL10% Owner 2016-08-05Sell2,241,000$14.6222.3view
Greiner Charles RVP - Global Franchise 2016-05-06Sell3,508$12.3145.25view
Trowbridge Stephen ASVP and General Counsel 2016-04-25Sell12,940$12.345.37view
Richard StarkSVP, GM - Oncology 2015-02-13Sell18,100$18.53-3.51view
Trowbridge Stephen ASVP and General Counsel 2014-10-29Sell0$0-3.51view
Greiner Charles RVP - Global Franchise 2014-10-20Sell3,298$15.6314.4view
Kapusta Matthew CSVP, Business Development 2014-04-14Buy1,000$13.928.63view

Press Releases about ANGO :

Quarterly/Annual Reports about ANGO:

News about ANGO:

Articles On GuruFocus.com
The Barclays Triggers More Insider Buying Mar 13 2013 
Weekly CEO Buys Highlight: JPM, ROG, PBY, ANGO, MCHX Jul 21 2012 
Weekly CEO Buys Highlight: WINA, ANGO, FES, LTS, TBOW Apr 15 2012 
Weekly CEO Buys Highlight: PKY, TWO, UVSP, AGYS, ANGO Feb 19 2012 
AngioDynamics Inc. Reports Operating Results (10-Q) Jan 07 2011 
AngioDynamics Inc. Reports Operating Results (10-Q) Oct 08 2010 
AngioDynamics Inc. Reports Operating Results (10-Q) Jan 08 2010 
AngioDynamics Inc. Reports Operating Results (10-Q) Oct 07 2009 
Weekly CEO Buys Highlight: CoBiz Financial Inc, Winmark Corp, The Greenbrier Companies Inc, AngioDyn Jul 26 2009 
Weekly CEO Buys Highlight: The Greenbrier Companies, AngioDynamics, Hallmark Financial Services, Ves Apr 18 2009 

More From Other Websites
ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 30 2017
Q3 2017 AngioDynamics Inc Earnings Release - Before Market Open Mar 30 2017
AngioDynamics tops 3Q profit forecasts Mar 30 2017
AngioDynamics tops 3Q profit forecasts Mar 30 2017
6:05 am AngioDynamics beats by $0.04, misses on revs; raises FY17 EPS above consensus, lowers FY17... Mar 30 2017
AngioDynamics Reports Fiscal 2017 Third Quarter Results Mar 30 2017
AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City Mar 27 2017
AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results Mar 20 2017
AngioDynamics Microwave Tissue Ablation System Now CE Marked Mar 15 2017
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System Mar 14 2017
AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 13,... Mar 13 2017
AngioDynamics to Present at the Barclays Global Healthcare Conference Mar 08 2017
Coverage initiated on AngioDynamics by Barclays Feb 08 2017
AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : January 20,... Jan 20 2017
ETFs with exposure to AngioDynamics, Inc. : January 19, 2017 Jan 19 2017
AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017 Jan 17 2017
ANGIODYNAMICS INC Financials Jan 12 2017
Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Jan 11 2017
ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 10 2017
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential... Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)